|Daily Range||$300.22 - $305.01|
|52-Week Range||$227.64 - $352.49|
|Dividend (Yield)||$0.00 (0.0%)|
|Average Daily Volume||971,330|
|Current FY EPS||$9.29|
How do you think REGN
will perform against the market?
Top REGN Bull/Bear Pitches
TMFTycoon (< 20)
Submitted March 20, 2014
Things are looking good for Eylea, one of Regeneron's drugs, and it is scheduled for further regulatory decisions and Phase III testing later this year.
Regeneron Pharmaceuticals, Inc. (REGN) Description
The Company is a biopharmaceutical company that discovers, develops, and intends to commercialize pharmaceutical products for the treatment of serious medical conditions. Website: http://www.regeneron.com/